Tag: glioblastoma

Our Research Engagement Manager Becky Birch, outlines developments highlighted by Tessa Jowell’s debate

Researchers have discovered that the circadian rhythm, also known as a person’s ‘internal clock’, could hold the answers to develop new therapies for glioblastoma

Patients with glioblastoma are wearing a cap that delivers electronic fields to treat their brain tumours

Researchers in collaboration with ZIOPHARM Oncology, a biopharmaceutical company announce positive updates on a Phase 1 clinical trials testing a new therapy

Researchers at Glasgow University have discovered that ovarian cancer drug, olaparib, has the potential to treat patients with glioblastomas

Gideon Burrows has written his second book with personal stories, experiences, statistics and information, helped by a huge amount of people directly affected

Last week Bristol-Myers Squibb announced the initial results from their Phase 3 clinical trial that was assessing the effectiveness and safety of the immunotherapy drug Nivolumab in patients with recurrent glioblastoma.

Researchers at McGill University Health Centre (MUHC), Montreal have developed a new clinical approach to enhance the efficiency of treatment for glioblastomas, which increased the average survival time to 22 months.

A new, promising clinical trial, led by Dr Stephen Price, is opening in the UK to look at how using advanced imaging methods can predict where a glioblastoma tumour is likely to grow back before any treatment is given. This study is the first of its kind to better understand this question.

Scientists at the University of Leeds have discovered that targeting a protein that helps cancer cells repair their DNA could lead to a new treatment for the highly aggressive brain tumour, glioblastoma (GBM).

A team at The Scripps Research Institute, USA, have been able to identify a cellular pathway used by glioblastoma (GBM) tumours to allow them to survive, that could be exploited therapeutically to halt tumour growth.

Published today in the journal eLife, the research targeted the ephrin-B2 protein and results demonstrate it halts the division of cancer cells and then stops them spreading.

New imaging technology may allow neurosurgeons to distinguish between tumour tissue and normal brain tissue in real time

An enhanced Australian rabbit virus may pave the way for future drug-virus treatments of GBM.